Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Immunotherapy. 2022 Nov; 14(16):1341-1351.